Abraxane now part of standard-of-care for patients with advanced pancreatic cancer, following studies at the Virginia G. Piper Cancer Center at Scottsdale Healthcare
Continue reading
Category Archives: AZBio News
NAU President John Haeger outlines succession plans
September 5, 2013 : Northern Arizona University – After 12 successful years as president of Northern Arizona University, John D. Haeger announced today that the lengthy process to search for his successor will begin soon.Continue reading
Opportunity Alert – Driving Innovation in Breast Cancer: Startup Challenge
The Avon Foundation (AF), National Institutes of Health National Cancer Institute (NCI) and Center for Advancing Innovation (CAI) have partnered to launch a “first of a kind” Business Plan and Start-Up Challenge for Breast Cancer (BC) inventions that have high commercial viability and are important to public health. This challenge will accelerate the commercialization of Federal agency and AF grantee BC inventions, spur economic growth, and provide Universities a platform to further develop their entrepreneurship learning portfolio.Continue reading
U.S. Food and Drug Administration Approves ABRAXANE® in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
-Approval Based on MPACT Study of ABRAXANE in Combination with Gemcitabine Demonstrating a Clinically Meaningful Increase in Overall Survival-
-First New Treatment Approved for Metastatic Adenocarcinoma of the Pancreas in Nearly 8 Years-Continue reading
NIH Awards HTG Molecular Additional $1.01M to Continue Development of Targeted Sequencing Product Concept
TUCSON, AZ–(Marketwired – Sep 4, 2013) – The National Human Genome Research Institute of the National Institutes of Health issued a Notice of Award granting a Phase II SBIR award of $1.01 million for HTG Molecular Diagnostics to continue the Nuclease Probe Mediated Sequencing Project (HTG EdgeSeq). The HTG EdgeSeq program will develop targeted sequencing products that leverage HTG Molecular Diagnostics’ core RNA analysis technology.Continue reading
Ventana and EMC join forces to take digital pathology into the world of Big Data
Tucson, AZ, September 4, 2013— Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has entered into an agreement with data storage and IT infrastructure industry leader EMC Corporation (EMC) to offer a highly scalable and flexible solution to store and archive medical images as part of the VENTANA digital pathology solution for anatomical pathology labs.Continue reading
Colleen M. Niccum Joins SALC as VP of Education Policy
The Southern Arizona Leadership Council (SALC) is proud to welcome Colleen M. Niccum as its Vice President of Education Policy.
Niccum recently retired from Raytheon Company following a 30-year career in the defense industry as a communications executive. During the past five years, she focused on expanding Raytheon’s community partnerships; improving science, technology, engineering and math (STEM) education in Arizona; and working with state and local government leaders to support the defense industry in Arizona.Continue reading
Opportunity Alert: Submit Your Ideas for Session Presentations at BIO 2014
The Call for Sessions opens September 5th for the
BIO International Convention
in San Diego, June 23-26, 2014.
Education enhancements in 2014 include: streamlined session tracks organized by role in the industry and featuring international representation among panels; specialty forums with cohesive content and targeted networking receptions.
- Basic Research & Discovery
- Business Development & Financing
- Clinical Trials & Product Testing
- Industrial Bioproducts
- Intellectual Property
- Manufacturing, Distribution & Operations
- Market Access & Commercialization
- Regulatory Review & Approval
- Specialty Forums on personalized medicine, agriculture technologies, vaccines, and transformational research
Start planning today: session proposals will be accepted Thursday, September 5 through Thursday, October 3, 2013.
How to develop our suggestion:
- Review the list of tracks and topic area suggestions to determine which topics are relevant and pressing
- Talk with colleagues and industry contacts about your idea; brainstorm potential speakers
- Use the Session Proposal Guide for step-by-step tips to maneuver the online submission process
Please note, proposals for the International Market Briefings (IMB) Track will be accepted separately October 14 – November 4, 2013.
With the 2014 BIO International Convention being held in San Diego, this is a great opportunity to show the world what Arizona has to offer.
QUESTIONS? If you have any questions about your topic, how to submit, etc. Email BIO at program@bio.org.
Visit convention.bio.org/pitch for more information.
Meet Town of Gilbert Mayor, John W. Lewis – 2013 AZBio Public Service Award Honoree
John W. Lewis, Mayor of the Town of Gilbert to receive the 2013 AZBio Public Service Award from the Arizona Bioindustry AssociationContinue reading
30 Never Looked So Good – PCH celebrates three decades
You are invited to the celebration
The evening event will include a program with Phoenix Business Journal publisher Don Henninger and Phoenix Children’s Hospital president and CEO, Bob Meyer discussing the hospital’s history and vision for the future. After the program a networking reception and birthday party will follow.
Join our community for this exciting occasion as we celebrate 30 years of contributions from this important organization in our community. It is our honor to help our friends at Phoenix Children’s Hospital to celebrate this milestone with the Valley’s business leaders.
Register Here – Proceeds from ticket sales will be donated to Phoenix Children’s Hospital Foundation. Seats are limited.
When: Wednesday, Sept. 18th from 5 p.m. to 7:30 p.m.
Where: Phoenix Children’s Hospital located at 1919 E. Thomas Rd. Phoenix
